We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

81 hedge funds and large institutions have $17.5M invested in Ampio Pharmaceuticals Inc. in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 7

143% more call options, than puts

Call options by funds: $784K | Put options by funds: $323K

56% more capital invested

Capital invested by funds: $11.2M → $17.5M (+$6.25M)

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

3% more funds holding

Funds holding: 79 → 81 (+2)

Holders
81
Holders Change
+2
Holders Change %
+2.53%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
7
Closed
14
Calls
$784K
Puts
$323K
Net Calls
+$461K
Net Calls Change
+$176K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$542K
2
First Trust Advisors
First Trust Advisors
Illinois
+$339K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$150K
4
BJL
Brighton Jones LLC
Washington
+$123K
5
WWM
Western Wealth Management
Colorado
+$104K

Top Sellers

Rank Fund Capital Flow
1
PCMC
Private Capital Management (Colorado)
Colorado
-$771K
2
BlackRock
BlackRock
New York
-$65.7K
3
TFS
TrustCore Financial Services
Tennessee
-$49.1K
4
MMA
Miracle Mile Advisors
California
-$25K
5
WS
Wedbush Securities
California
-$21.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$78K +$50.1K +202 +285%
Charles Schwab
27
Charles Schwab
California
$71K – – –
CPIG
28
Chicago Partners Investment Group
Illinois
$69K +$17.6K +71 +35%
WS
29
Wedbush Securities
California
$63K -$21.6K -87 -28%
RJFSA
30
Raymond James Financial Services Advisors
Florida
$63K +$1.24K +5 +2%
DIA
31
Dana Investment Advisors
Wisconsin
$62K – – –
Citadel Advisors
32
Citadel Advisors
Florida
$57K +$20.8K +84 +73%
UCFA
33
United Capital Financial Advisors
Texas
$53K +$1.74K +7 +4%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$50K +$43.1K +174 New
Osaic Holdings
35
Osaic Holdings
Arizona
$49K +$20.6K +83 +93%
State Street
36
State Street
Massachusetts
$45K – – –
Wolverine Trading
37
Wolverine Trading
Illinois
$39K -$6.2K -25 -15%
HighTower Advisors
38
HighTower Advisors
Illinois
$35K +$30.5K +123 New
JWA
39
JFS Wealth Advisors
Pennsylvania
$34K – – –
IWM
40
IHT Wealth Management
Illinois
$34K +$29.7K +120 New
Commonwealth Equity Services
41
Commonwealth Equity Services
Massachusetts
$31K +$9.91K +40 +57%
KWM
42
Kingsview Wealth Management
Oregon
$29K – – –
BIAS
43
Beacon Investment Advisory Services
New Jersey
$29K +$24.8K +100 New
HAG
44
HighPoint Advisor Group
Illinois
$28K – – –
Victory Capital Management
45
Victory Capital Management
Texas
$25K +$248 +1 +1%
SBIA
46
Sheaff Brock Investment Advisors
Indiana
$25K +$991 +4 +5%
CCB
47
Cutter & Co Brokerage
Missouri
$24K – – –
BWM
48
BT Wealth Management
Georgia
$24K +$20.6K +83 New
MAM
49
Marotta Asset Management
Virginia
$23K – – –
BFG
50
Baron Financial Group
New Jersey
$22.5K +$19.3K +78 New
1
2
3 4

AMPE Hedge Fund Activity: Q3 2020 in Review

81 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2020, worth a combined $17.5M — up 56% from $11.2M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AMPE positions and 14 closed out — a net gain of 2 holders — while 24 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $542K. The largest seller was Private Capital Management (Colorado), exiting entirely with an estimated $771K sold.

  • 81 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2020, up from 79 in Q2 2020.
  • Funds reported $17.5M of Ampio Pharmaceuticals Inc. stock for Q3 2020, up 56% quarter-over-quarter.
  • 16 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2020 and 14 closed out, a net change of +2 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2020 was Vanguard Group, an estimated $542K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2020 was Private Capital Management (Colorado), an estimated $771K sold.

Based on aggregated 13F filings for Q3 2020.